These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9973918)

  • 21. Detection of monosomy 7 and trisomies 8 and 11 in myelodysplastic disorders by interphase fluorescent in situ hybridization. Comparison with acute non-lymphocytic leukemias.
    Brizard F; Brizard A; Guilhot F; Tanzer J; Berger R
    Leukemia; 1994 Jun; 8(6):1005-11. PubMed ID: 8207973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discordant detection of monosomy 7 by GTG-banding and FISH in a patient with Shwachman-Diamond syndrome without evidence of myelodysplastic syndrome or acute myelogenous leukemia.
    Sokolic RA; Ferguson W; Mark HF
    Cancer Genet Cytogenet; 1999 Dec; 115(2):106-13. PubMed ID: 10598142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conventional cytogenetics and fluorescence in situ hybridization in persistent cytopenias and myelodysplastic syndromes in childhood.
    Touliatou V; Kolialexi A; Tsangaris GT; Moschovi M; Polychronopoulou S; Mavrou A
    Anticancer Res; 2004; 24(6):3945-9. PubMed ID: 15736436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multimodal approach in the diagnosis of patients with hematopoietic disorders.
    Mark HF; Gray Y; Mark Y; Khorsand J; Sikov W
    Cancer Genet Cytogenet; 1999 Feb; 109(1):14-20. PubMed ID: 9973954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity of lineage involvement by trisomy 8 in myelodysplastic syndrome. A multiparameter analysis combining conventional cytogenetics, DNA in situ hybridization, and bone marrow culture studies.
    Fagioli F; Cuneo A; Bardi A; Carli MG; Bigoni R; Balsamo R; Previati R; Pazzi I; Roberti G; Rigolin GM
    Cancer Genet Cytogenet; 1995 Jul; 82(2):116-22. PubMed ID: 7664240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current treatment options: impact of cytogenetics on the course of myelodysplasia.
    Galili N; Cerny J; Raza A
    Curr Treat Options Oncol; 2007 Apr; 8(2):117-28. PubMed ID: 17634837
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes.
    Kibbelaar RE; van Kamp H; Dreef EJ; de Groot-Swings G; Kluin-Nelemans JC; Beverstock GC; Fibbe WE; Kluin PM
    Blood; 1992 Apr; 79(7):1823-8. PubMed ID: 1558974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of cytogenetic abnormalities involving chromosomes 5,7 and 8 in myelodysplastic syndromes with fluorescence in situ hybridization and its clinical significance].
    Cai Y; Qin YW; Wang C; Yang J; Yan SK
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):6-10. PubMed ID: 17649717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.
    Beyer V; Castagné C; Mühlematter D; Parlier V; Gmür J; Hess U; Kovacsovics T; Meyer-Monard S; Tichelli A; Tobler A; Jacky E; Schanz U; Bargetzi M; Hagemeijer A; de Witte T; van Melle G; Jotterand M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):29-41. PubMed ID: 15193439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantity of clonal cells detected by conventional cytogenetic analysis correlates with bone marrow blasts and survival in myelodysplastic syndromes.
    Kim M; Chung S; See CJ; Yoon SS; Kim BK; Kim HK; Lee DS
    Leuk Res; 2012 Feb; 36(2):163-8. PubMed ID: 21920602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interphase cytogenetic analysis of in vivo differentiation in the myelodysplasia of Down syndrome.
    Zipursky A; Wang H; Brown EJ; Squire J
    Blood; 1994 Oct; 84(7):2278-82. PubMed ID: 7919346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantifying chromosome changes and lineage involvement in myelodysplastic syndrome (MDS) using fluorescent in situ hybridization (FISH).
    Han K; Lee W; Harris CP; Kim W; Shim S; Meisner LF
    Leukemia; 1994 Jan; 8(1):81-6. PubMed ID: 8289503
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of common chromosome abnormalities in myelodysplastic syndrome with a panel fluorescence in situ hybridization].
    Shen Y; Xue Y; Li J; Pan J; Wu Y; Chen S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):160-3. PubMed ID: 12673589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clonal chromosomal aberrations in patients with aplastic anemia at the disease onset and transformation].
    Ol'shanskaia IuV; Mikhaĭlova EA; Domracheva EV; Udovichenko AI; Davidian IuR; Vodinskaia LA; Zakharova AV; Kokhno AV; Kaplanskaia IB; Tikhonova LIu; Tsvetaeva NV; Parovichnikova EN; Savchenko VG
    Ter Arkh; 2006; 78(7):31-4, 36-7. PubMed ID: 16944748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal origin and evolution of myelodysplastic syndrome analyzed by dysplastic morphology and fluorescence in situ hybridization.
    Fu CM; Chen ZX; Liu DD; Zhang J; Pan JL; Liang JY
    Int J Hematol; 2015 Jan; 101(1):58-66. PubMed ID: 25430081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myelodysplastic syndrome associated with trisomy 2.
    Heller M; Provan D; Amess JA; Dixon-McIver A
    Clin Lab Haematol; 2005 Aug; 27(4):270-3. PubMed ID: 16048496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
    Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
    Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytogenetic abnormalities in myelodysplastic syndrome: an overview.
    Kawankar N; Vundinti BR
    Hematology; 2011 May; 16(3):131-8. PubMed ID: 21669051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytogenetics and fluorescence in-situ hybridization in detection of hematological malignancies.
    Frenny VJ; Antonella Z; Luisa A; Shah AD; Sheth JJ; Rocchi M
    Indian J Cancer; 2003; 40(4):135-9. PubMed ID: 14716109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes.
    Saumell S; Florensa L; Luño E; Sanzo C; Cañizo C; Hernández JM; Cervera J; Gallart MA; Carbonell F; Collado R; Arenillas L; Pedro C; Bargay J; Nomdedeu B; Xicoy B; Vallespí T; Raya JM; Belloch L; Sanz GF; Solé F
    Br J Haematol; 2012 Nov; 159(3):311-21. PubMed ID: 22958186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.